NIPH
AMRI

NN Investment Partners Holdings’s Albany Molecular Research Inc AMRI Stock Holding History

NN Investment Partners Holdings’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-41,890
Closed -$588K – 951
2017
Q1 		$588K Sell
41,890
-7,155
-15% -$117K 0.01% 510
2016
Q4 		$920K Sell
49,045
-620
-1% -$10.5K 0.01% 486
2016
Q3 		$820K Buy
49,665
+520
+1% +$7.7K 0.01% 520
2016
Q2 		$661K Sell
49,145
-1,220
-2% -$17.8K 0.01% 542
2016
Q1 		$770K Buy
+50,365
New +$789K 0.01% 514

Other funds holding AMRI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
American Capital Management New York $1.86B AUM 20.23% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CCM
Chicago Capital Management Chicago, Illinois $112M AUM 76.54% 1-Year Est. Return
EWM
Evercore Wealth Management New York $6.36B AUM 20.35% 1-Year Est. Return

NN Investment Partners Holdings's AMRI Position: Q2 2017 in Review

NN Investment Partners Holdings sold out of Albany Molecular Research Inc (AMRI) in Q2 2017, closing a stake of 41,890 shares — an estimated $588K sold.

NN Investment Partners Holdings first reported a position in AMRI in Q1 2016 and held it in 5 quarters. The position peaked at $920K in Q4 2016. 136 funds tracked by Wall St. Rank hold AMRI as of Q2 2017.

  • NN Investment Partners Holdings reported no remaining Albany Molecular Research Inc position as of Q2 2017 after selling out during the quarter.
  • NN Investment Partners Holdings sold 41,890 Albany Molecular Research Inc shares in Q2 2017, an estimated $588K.
  • NN Investment Partners Holdings first reported a position in Albany Molecular Research Inc in Q1 2016 and held it in 5 quarters.
  • NN Investment Partners Holdings's Albany Molecular Research Inc position peaked at $920K in Q4 2016.
  • 136 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q2 2017.

Based on NN Investment Partners Holdings's 13F filing for Q2 2017, filed 12 Jul 2017.